Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

Fresenius Kabi USA, LLC: Ketorolac Tromethamine Injection Recalled for Presence of Particulate Matter

Agency Publication Date: June 8, 2020
Share:
Sign in to monitor this recall

Summary

Fresenius Kabi USA is recalling approximately 8.8 million vials of Ketorolac Tromethamine Injection, USP, a prescription nonsteroidal anti-inflammatory drug (NSAID) used for pain management. The recall was initiated after particulate matter (foreign particles) was discovered in reserve sample vials at the manufacturing firm. Consumers and healthcare facilities should immediately identify if they have the affected 1 mL or 2 mL single-dose vials, as the presence of particles in an injectable medication can lead to serious health complications. This recall affects various lots distributed nationwide across the United States and Puerto Rico.

Risk

Injecting a product containing particulate matter can cause local irritation, swelling, or infection at the injection site. If the particles travel through the bloodstream, they can cause more severe issues such as blood clots, inflammation of the blood vessels, or blockages in vital organs like the lungs or heart.

What You Should Do

  1. Check your supply for Ketorolac Tromethamine Injection 30 mg per mL (1 mL vials) with NDC 63323-162-00 and look for the following lot numbers and expiration dates: 6118737 (Exp 04/2020), 6118902 (Exp 04/2020), 6119052 (Exp 05/2020), 6119752 (Exp 08/2020), 6122349 (Exp 07/2021), and 6122538 (Exp 09/2021).
  2. Check your supply for Ketorolac Tromethamine Injection 60 mg per 2 mL (2 mL vials) with NDC 63323-162-03 and look for the following lot numbers and expiration dates: 6119229 (Exp 06/2020), 6119273 (Exp 06/2020), 6119843 (Exp 09/2020), 6121115 (Exp 02/2021), 6121451 (Exp 03/2021), 6121452 (Exp 03/2021), and 6121496 (Exp 03/2021).
  3. Immediately stop using any vials matching these identified lot numbers and set them aside to ensure they are not administered to patients.
  4. Contact your healthcare provider or pharmacist immediately if you have used this product and are experiencing any unusual symptoms or health concerns.
  5. Return any unused product to the pharmacy or place of purchase for a refund and contact Fresenius Kabi USA for further instructions regarding the return process.
  6. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Healthcare provider consultation and pharmacy return.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Ketorolac Tromethamine Injection, USP, 30 mg per mL (1 mL Single Dose Vials)
Model:
NDC 63323-162-00
NDC 63323-162-01
Lot Numbers:
6118737 (Exp 04/2020)
6118902 (Exp 04/2020)
6119052 (Exp 05/2020)
6119752 (Exp 08/2020)
6122349 (Exp 07/2021)
6122538 (Exp 09/2021)
Date Ranges: 04/2020, 05/2020, 08/2020, 07/2021, 09/2021
Product: Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (2 mL Single Dose Vials)
Model:
NDC 63323-162-03
NDC 63323-162-02
Lot Numbers:
6119229 (Exp 06/2020)
6119273 (Exp 06/2020)
6119843 (Exp 09/2020)
6121115 (Exp 02/2021)
6121451 (Exp 03/2021)
6121452 (Exp 03/2021)
6121496 (Exp 03/2021)
Date Ranges: 06/2020, 09/2020, 02/2021, 03/2021

Product Images

Ketorolac Tromethamine Injection, USP, 30 mg/mL label

Ketorolac Tromethamine Injection, USP, 30 mg/mL label

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL label

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL label

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 85504
Status: Resolved
Manufacturer: Fresenius Kabi USA, LLC
Sold By: hospitals; clinics; pharmacies
Manufactured In: United States
Units Affected: 2 products (5,314,400 vials; 3,497,575 vials)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.